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ABSTRACT
Preserving mitochondrial mass, bioenergetic functions and
ROS (reactive oxygen species) homoeostasis is key to
neuronal differentiation and survival, as mitochondria
produce most of the energy in the form of ATP to execute
and maintainthese cellularprocesses. Inviewofour previous
studies showing that NeuroD6 promotes neuronal differ-
entiation and survival on trophic factor withdrawal,
combined with its ability to stimulate the mitochondrial
biomass and to trigger comprehensive antiapoptotic and
molecular chaperone responses, we investigated whether
NeuroD6 could concomitantly modulate the mitochondrial
biomass and ROS homoeostasis on oxidative stress mediated
by serum deprivation. In the present study, we report a novel
role of NeuroD6 as a regulator of ROS homoeostasis,
resulting in enhanced tolerance to oxidative stress. Using a
combination of flow cytometry, confocal fluorescence
microscopy and mitochondrial fractionation, we found that
NeuroD6sustainsmitochondrialmass,intracellular ATPlevels
and expression of specific subunits of respiratory complexes
upon oxidative stress triggered by withdrawal of trophic
factors. NeuroD6 also maintains the expression of nuclear-
encoded transcription factors, known to regulate mitochon-
drial biogenesis, such as PGC-1a (peroxisome-proliferator-
activated receptor c co-activator-1a), Tfam (transcription
factor A, mitochondrial) and NRF-1 (nuclear respiratory
factor-1). Finally, NeuroD6 triggers a comprehensive anti-
oxidant response to endow PC12-ND6 cells with intracellular
ROS scavenging capacity. The NeuroD6 effect is not limited
to the classic induction of the ROS-scavenging enzymes,
such as SOD2 (superoxide dismutase 2), GPx1 (glutathione
peroxidase 1) and PRDX5 (peroxiredoxin 5), but also to the
recently identified powerful ROS suppressors PGC-1a,P I N K 1
(phosphatase and tensin homologue-induced kinase 1) and
SIRT1. Thus our collective results support the concept that
the NeuroD6–PGC-1a–SIRT1 neuroprotective axis may be
critical in co-ordinating the mitochondrial biomass with the
antioxidant reserve to confer tolerance to oxidative stress.
Key words: mitochondria, NeuroD family, neuronal survival,
reactive oxygen species (ROS), SIRT1, transcriptional co-
regulator peroxisome-proliferator-activated receptor c co-
activator-1a (PGC-1a).
INTRODUCTION
A wealth of studies have demonstrated that both mitochon-
drial dysfunction and oxidative stress are implicated in the
pathogenesis of several neurodevelopmental disorders, such
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asnneuro.org / Volume 2 (2) / art:e00034 115as spongiform encephalopathy (Melov et al., 2001; Golden et
al., 2005), mitochondrial encephalopathy (Wallace, 1999;
Patel, 2004; Khurana et al., 2008) and autism spectrum
disorder (James et al., 2004, 2006; Pons et al., 2004; Chauhan
and Chauhan, 2006; Rossignol and Bradstreet, 2008) as well
as many neurodegenerative diseases, such as PD (Parkinson’s
disease), AD (Alzheimer’s disease), HD (Huntington’s disease)
and ALS (amyotrophic lateral sclerosis) (reviewed by Finkel
and Holbrook, 2000; Fridovich, 2004; Wallace, 2005; Lin and
Beal, 2006; Giorgio et al., 2007; Nicholls, 2008; Malkus et al.,
2009). Thus preserving mitochondrial mass and function is
key to neuronal differentiation and survival, as mitochondria
produce most of the energy in the form of ATP through a
series of oxidative reactions occurring in the ETC (electron
transfer chain) necessary to execute and maintain neuronal
differentiation in a developing or mature brain.
Mitochondria, being a key source of ROS (reactive oxygen
species) as a result of electron transfer through the respiratory
chain at the level of both complex I [COX1 (NADH: ubiquinone
oxidoreductase)] and complex III (COX3; ubiquinone-cyto-
chrome c reductase) (Sugioka et al., 1988; Trumpower, 1990;
Demin et al., 1998; Han et al., 2001; St-Pierre et al., 2002; Chen
et al., 2003), possess an intrinsic defence system to regulate
ROShomoeostasis via the expression of an array of antioxidant
regulators, such as non-enzymatic regulators (a-tocopherol,
coenzyme Q10, cytochrome c and glutathione) and detoxifying
enzymes [SOD (superoxide dismutase), glutathione peroxidase
and peroxiredoxins] (reviewed by Finkel and Holbrook, 2000).
Increased ROS production leads to oxidative damage of the
mtDNA (mitochondrial DNA), potentially due to its limited
repair system and location in the mitochondrial matrix near
the released ROS (Esposito et al., 1999; Melov et al., 1999;
Balaban et al., 2005), resulting in compromised mitochondrial
function and integrity as well as further increased ROS levels.
Given the fact that mitochondria assume the dual role of
regulating neuronal survival and controlling ROS levels, the
degree of vulnerability of developing and mature neurons is
most likely correlated to their functional mitochondrial mass
and the extent of their antioxidant reserve. Thus it is of great
interest to identify neurogenic transcription factors promoting
interconnected transcriptional networks responsible for co-
ordinating the mitochondrial biomass with a comprehensive
antioxidant response, which can be tailored to developmental
and cellular contexts. The neurogenic bHLH (basic helix–loop–
helix) transcription factor NeuroD6 is an excellent candidate to
assume such a dual function, based on our previous findings
showing its role as a co-regulator of mitochondrial mass,
cytoskeletal remodelling, anti-apoptotic and molecular cha-
perone networks (Uittenbogaard and Chiaramello, 2002, 2005;
Baxter et al., 2009; Uittenbogaard et al., 2009, 2010).
NeuroD6 (previously known as Nex1/MATH-2) is a member
of the neurogenic bHLH NeuroD family, which contributes to
the specification of multipotential progenitors towards a
glutamatergic pyramidal fate (Schwab et al., 1998; Wu et al.,
2005). It remains expressed in the adult brain in areas
associated with higher cognitive functions, such as the
hippocampus, the neocortex and the entorhinal cortex, the
first area to be affected in AD (Alzheimer’s disease)
(Bartholoma ¨ and Nave, 1994; Shimizu et al., 1995). Due to
functional redundancy between members of the NeuroD
family, NeuroD6’s role during brain development has remained
elusive (Schwab et al., 2000). Using our in vitro cellular
paradigm, the PC12-ND6 cell line, which constitutively over-
expresses NeuroD6 independently of NGF (nerve growth
factor) signalling, we have demonstrated that NeuroD6
initiates neuronal differentiation, while promoting neuronal
survival via the expression of anti-apoptotic regulators
preserving mitochondrial integrity, such as Bcl-XL, Bcl-w,
survivin and XIAP (X-linked inhibitor of apoptosis;
Uittenbogaard and Chiaramello, 2002, 2004, 2005). Using a
genome-wide microarray approach, we further identified
NeuroD6-mediated transcriptional pathways linking neuronal
differentiation to survival upon oxidative stress induced by
serum deprivation. By applying a gene set enrichment strategy,
we found that NeuroD6 regulates an extensive molecular
chaperone network through the expression of a multitude of
HSPs (heat-shock proteins), combined with increased express-
ion of genes involved in mitochondrial biogenesis, bioener-
getics and oxidative metabolism (Uittenbogaard et al., 2010).
Most importantly, these genomic microarray-based findings
are in keeping with our recently published study reporting a
novel role for NeuroD6 in stimulating mitochondrial mass and
ATP levels during the very early stages of neuronal differenti-
ation (Baxter et al., 2009).
The main objective of the present study was to
investigate whether NeuroD6 could maintain the mitochon-
drial biomass while triggering an antioxidant response upon
oxidative stress induced by serum deprivation. Our original
impetus was based on our previously reported NeuroD6-
mediated long-term neuronal survival upon serum removal
(Uittenbogaard and Chiaramello, 2005) combined with our
recent microarray analysis suggestive of a co-ordinate
expression between NeuroD6, mitochondria-related genes
and a cluster of ROS-scavenging genes (Uittenbogaard et
al., 2010). Using a combination of flow cytometry, confocal
fluorescence microscopy and mitochondrial fractionation,
we found that NeuroD6 sustained the mitochondrial
content of serum-deprived PC12-ND6 cells, accompanied
by maintained intracellular ATP levels and expression of key
subunits of various respiratory complexes of the ETC.
Furthermore, NeuroD6 triggered a comprehensive antiox-
idant response co-ordinated with the expression of key
mitochondrial regulators, such as PINK1 (phosphatase and
tensin homologue-induced kinase 1), PGC-1a (peroxisome-
proliferator-activated receptor c co-activator-1a)a n d
SIRT1, resulting in low ROS levels upon oxidative stress
mediated by serum withdrawal. Thus the present study
provides the first evidence of a novel function of the
neurogenic bHLH transcription factor NeuroD6 as a
regulator of ROS homoeostasis. Combined with our previous
studies, our results support the notion that NeuroD6 plays
an integrative role in co-ordinating mitochondrial content
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MATERIALS AND METHODS
Cell culture
Control rat pheochromocytoma PC12 cells and PC12-ND6 cells
(previously referred to as Nex1/MATH-2-overexpressing PC12-
Nex1 cells) were grown on collagen I-coated plates (Becton
Dickinson Labware, San Jose, CA, U.S.A.) in F12K modified
medium (Kaighn’s modification) supplemented with 2.5% (v/v)
fetal bovine serum and 15% (v/v) horse serum (Invitrogen,
Carlsbad, CA, U.S.A.), as described in Uittenbogaard and
Chiaramello (2002). For serum deprivation, cells were seeded
at 70% confluency and then washed on the following day
three times with serum-free medium, as described in
Uittenbogaard and Chiaramello (2005).
Immunoblot analysis
Serum-grown control PC12 and PC12-ND6 cells as well as
serum-deprived PC12-ND6 cells were lysed for specific time
periods as indicated in the Figure legends in M-per mammalian
protein extraction buffer (Pierce Biotechnology, Rockford, IL,
U.S.A.) in the presence of a cocktail of protease inhibitors
(Roche AppliedScience, Indianapolis, IN,U.S.A.), as described in
Uittenbogaard et al. (2010). Proteins (40 mg) were resolved on
10% NuPAGE Bis-Tris gels (Invitrogen) with either Mes/SDS or
Mops/SDS running buffer and transferred to the nitrocellulose.
Nitrocellulose membranes were stained with Ponceau-S
(Sigma, St. Louis, MO, U.S.A.) to confirm uniform transfer of
proteins and subsequently blocked using Superblock
TM block-
ing buffer (Pierce). The membranes were probed with various
antibodies described in Table 1 and corresponding secondary
horseradish peroxidase-conjugated antibodies (Pierce). The
antigen–antibody complex was detected using the Supersignal
West Pico Chemiluminescent Substrate kit (Pierce). Blots were
then stripped using Restore
TM Western blot stripping buffer
(Pierce) according to the manufacturer’s recommendations,
and re-probed with a monoclonal antibody against GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) to confirm
equal protein loading. Protein levels visualized by immunoblot
analyses were quantified using the NIH (National Institutes of
Health) ImageJ software (http://rsb.info.nih.gov/ij/) and nor-
malized against the GAPDH loading control as described in
Uittenbogaard et al. (2010).
Flow cytometry
Flow cytometry was performed as described in Baxter et al.
(2009). Briefly, cells were grown on collagen I-coated plates
to 80% confluency before staining with 70 nM MTG
(MitoTrackerH Green; Molecular Probes, Eugene, OR, U.S.A.)
for 30 min at 37˚C, washed with PBS and trypsizined before
being centrifuged at 228 g for 5 min and analysed with a
FACSCalibur
TM flow cytometer (BD Bioscience, San Jose, CA,
U.S.A.). Data were collected from 20000 cells for each sample
and analysed using CellQuant software (BD Biosciences).
Mitochondrial area measurement
The mitochondrial area was measured using the histogram
function of ImageJ software as described in Baxter et al.
(2009). The cytoplasm was delineated using a combination of
Alexa FluorH 488-conjugated WGA (wheatgerm agglutinin;
Molecular Probes) and TO-PROH-3 staining (Molecular Probes).
Table 1 List of antibodies used for immunoblot analyses and immunocytochemistry
Abbreviations: Ab, antibody; IB, immunoblot; ICC, immunocytochemistry; mAb, monoclonal antibody; NA, not applicable; Rb, rabbit.
Antibody Type Source (catalogue no.) Dilution for IB Dilution for ICC
Alexa FluorH 488 anti-rabbit IgG Goat Ab Invitrogen (A11034) NA 1:2000
Alexa FluorH 568 anti-rabbit IgG Goat Ab Invitrogen (A11036) NA 1:2000
ATP synthase a (COX5) Mouse mAb Mitosciences (MS502) 1:1000 1:200
COX1 (NDUFA9) Mouse mAb Mitosciences (MS111) 1:1000 1:200
COX3 (core2 protein) Mouse mAb Mitosciences (MS304) 1:1000 1:1000
COX4 (subunit IV) Mouse mAb Abcam (ab14744) 1:500 NA
Drp1 Mouse mAb Abcam (ab56788) 1:400 NA
GAPDH Mouse mAb Ambion (4300) 1:10000 NA
Gpx1 Rb Ab Abcam (ab59564) 1:3000 NA
Mfn2 Rb Ab Abcam (ab50838) 1:1000 NA
NRF1 Rb Ab Abcam (ab34682) 1:5000 NA
NRF2 (GABP-a) Mouse mAb Santa Cruz (sc-28312) 1:200 NA
OPA-1 Rb Ab Abcam (ab42364) 1:500 NA
Pink1 Rb Ab Abcam (ab23707) 1:250 NA
PGC-1a Rb Ab Santa Cruz (sc-13067) 1:500 NA
Prdx5 Rb Ab Abcam (ab16823) 1:5000 NA
SIRT1 Goat Ab Santa Cruz (sc-19857) 1:1000 NA
SOD1 Rb Ab Abcam (ab16831) 1:10000 NA
SOD2 Rb Ab Abcam (ab13534) 1:2000 1:500
Tfam Goat Ab Santa Cruz (sc-23588) 1:1000 NA
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117Mitochondrial fractionation
Mitochondria-enriched fractions were isolated using a
mitochondrial/cytosol fractionation kit (Sigma) as described
in Baxter et al. (2009). Briefly, serum-grown and serum-
deprived control PC12 and PC12-ND6 cells were trypsinized,
centrifuged at 600 g for 5 min, washed twice with PBS and
resuspended in an extraction buffer in the presence of
protease inhibitors. Cells were gently homogenized using a
Dounce homogenizer and the degree of homogenization was
visualized by Trypan Blue staining. The homogenate was
centrifuged at 1000 g for 10 min at 4˚C. The supernatant was
centrifuged again at 3500 g for 10 min at 4˚C and the
pelleted mitochondria were lysed with the lysis buffer
provided in the presence of protease inhibitors. Protein
concentration was determined by the Bradford assay (Bio-
Rad Laboratories, Hercules, CA, U.S.A.).
Live cell imaging and mitochondrial morphology
Mitochondria of PC12-ND6 cells were labelled by electropora-
tion (BTX, Harvard Apparatus, Holliston, MA, U.S.A.) using the
GFP (green fluorescent protein)-mito vector (BD Pharmingen,
San Jose, CA, U.S.A.), which encodes the GFP (green fluorescent
protein) with the mitochondrial targeting sequence from
subunit VIII of human COX. After 24 h of transfection, PC12-
ND6 cells were grown on PDL (poly-D-lysine)-coated glass-
bottom dishes (Warner Instruments, Hamden, CT, U.S.A.) in the
presence or absence of serum for 48 h. Mitochondrial
morphology was assessed using a 6100 Planapo Chromat (NA
1.4) objective and a Zeiss 510 LSM confocal system (Zeiss,
Thornwood, NY, U.S.A.) equipped with TempModuleS and CO2
Module (Zeiss) to maintain the temperature and CO2 levels at
37˚C and 5.0% respectively and the Zen navigation software
(version 4.5; 2007) interface.
Measurement of intracellular ATP levels
Intracellular ATP levels were measured using the fluorescent
dye Mg-Gr (Magnesium Green)-AM (acetoxymethyl ester)
(Molecular Probes) as described in Bernstein and Bamburg
(2003). Mg-Gr decreases emission intensity (lex5475 nm;
lem5530 nm) with an increase in ATP levels due to its high
binding affinity to ATP, as compared with that of ADP
(Bernstein and Bamburg, 2003; Lee and Peng, 2008). Serum-
grown and serum-deprived control PC12 and PC12-ND6 cells
were labelled with 10 mM Mg-Gr resuspended in F12K serum-
and Phenol Red-free medium (Invitrogen) for 30 min at 37˚C.
Cells were washed twice with PBS before being trypsinized
and collected at 1300 g for 5 min and analysed with a
FACSCalibur
TM flow cytometer. Data were collected from
20000 cells and three independent experiments.
ROS quantification
Control PC12 and PC12-ND6 cells were grown on PDL-coated
glass-bottom dishes, labelled with 0.5 mg/ml Hoechst 33342
(Invitrogen)for30minand2.5mMMitoSOX
TMRed(Invitrogen)
for 10 min at 37˚C. Cells were imaged in Hoechst 33342 and
MitoSOX
TM-free media with a 663 Planapo Chromat (NA 1.4)
objective using a Zeiss 510 LSM confocal system equipped with
TempModuleS and CO2 Module. Using DIC (differential
interference contrast) images to delineate the cells, the mean
fluorescence intensity of MitoSOX
TM labelling was calculated
for each cell using NIH ImageJ software.
Immunocytochemistry and confocal fluorescence
microscopy
For immunocytochemistry labelling, serum-grown PC12-ND6
cells were first seeded on to PDL-coated coverslips (Electron
MicroscopySciences,Hatfield,PA,U.S.A.)placedina6-wellplate
(Nunc, Rochester, NY, U.S.A.). For serum deprivation, cells were
extensively washed with serum-free medium and grown in the
absence of serum for 48 h. Immunocytochemistry and confocal
fluorescencemicroscopywerecarriedoutasdescribedinBaxter
et al. (2009). Mitochondria were labelled by incubating cells in
the presence of 500 nM MTR (MitoTrackerH Red; Molecular
Probes) for 10 min at 37˚C, as described in Baxter et al. (2009).
Samples were fixed in 4.0% (w/v) paraformaldehyde (Electron
MicroscopySciences)for5min,andpermeabilizedin0.2%Triton
X-100 for 5 min. Cells were then blocked in 10% goat serum
(Invitrogen)for 1 h at room temperature (25˚C). Allprimaryand
secondary antibody incubations were performed at room
temperature as follows: 1 h incubation with primary antibodies
(Table 1), diluted in PBS, followed by 1 h incubation with the
appropriate Alexa FluorH-conjugated secondary antibodies
diluted 1:1000 in PBS (Table 1). When indicated, cells were
incubated with either nuclear counterstain TO-PROH-3 or DAPI
(49,6-diamidino-2-phenylindole)(MolecularProbes).Allsamples
were then mounted with Fluoromount G (Electron Microscopy
Sciences). Images were acquired with a 663 Planapo Chromat
(NA 1.4) objective using a Zeiss LSM 710 confocal system.
Statistical analysis
Statistical analyses were performed using the unpaired
Student’s t test. P values less than 0.05 were considered
statistically significant. Data are expressed as means¡S.D.
RESULTS
Constitutive expression of NeuroD6 in PC12-ND6
cells leads to maintained mitochondrial biomass
upon oxidative stress mediated by serum
deprivation
On the basis of NeuroD6-mediated increase in mitochondrial
mass during the early stages of neuronal differentiation
M Uittenbogaard, KK Baxter and A Chiaramello
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anti-apoptotic Bcl-2 members known to protect mitochon-
drial integrity (Uittenbogaard and Chiaramello, 2005;
Uittenbogaard et al., 2009), we hypothesized that NeuroD6
could maintain the mitochondrial biomass of PC12-ND6 cells
upon withdrawal of trophic factors. We used serum
deprivation as an oxidative stress paradigm (Satoh et al.,
1996), based on our previous studies showing that constitu-
tive expression of NeuroD6 endows the PC12-ND6 cells with
long-term survival properties while keeping them metaboli-
cally active (Uittenbogaard and Chiaramello, 2005). To test
this hypothesis, we used three distinct but complementary
experimental approaches: flow cytometry, confocal fluor-
escence microscopy and mitochondrial-enriched fractiona-
tion.
To initiate our studies, we isolated mitochondrial-enriched
fractions from control PC12 and PC12-ND6 cells grown in the
presence or absence of serum for 24 and 48 h respectively.
Mitochondrial fractionation using control PC12 cells could
not be performed beyond 24 h of serum deprivation due to
loss of PC12 cells adherence and extensive apoptosis
accompanied by caspase activation, cytochrome c leakage
into the cytosol as a result of compromised mitochondrial
membrane integrity, chromatin condensation and extensive
membrane blebbing (Stefanis et al., 1996, 1998; Troy et al.,
1997; Franc ¸ois et al., 2001; Vyas et al., 2004; Uittenbogaard
and Chiaramello, 2005). Results are expressed as a percentage
of total protein content of the corresponding whole-cell
extract, as described in Baxter et al. (2009). While PC12-ND6
cells displayed a statistically significant (P50.0153) 20%
increase in their mitochondrial protein content after 48 h of
serum deprivation, control PC12 cells lost more than 50% of
their mitochondrial protein content after 24 h of serum
deprivation (Figure 1A). Furthermore, serum-deprived PC12-
ND6 cells (48 h) exhibit an 11-fold increase in mitochondrial
protein content, as compared with that of serum-deprived
control PC12 cells (24 h), in keeping with the reported
increased survival capacity upon NeuroD6 expression
(Uittenbogaard and Chiaramello, 2005; Uittenbogaard et al.,
2010). Using a monoclonal antibody against COX4, we found
a 2.3-fold decrease in COX4 expression to negligible levels in
mitochondria-enriched fractions from serum-deprived (for 24
h) control PC12 cells, as compared with serum-grown control
PC12 cells (Figure 1A, right panel). This stands in contrast
with maintained COX4 expression levels in PC12-ND6 cells
after 48 h of serum deprivation (Figure 1A, right panel). It
bears mentioning that serum-grown PC12-ND6 cells exhib-
ited higher levels of COX4 expression than serum-grown
control PC12 cells, in keeping with the observed increase in
mitochondrial protein content upon NeuroD6 expression
(Figure 1A, left panel).
We further quantified the mitochondrial biomass in serum-
grown and serum-deprived PC12 ND6 cells using flow
cytometry by staining PC12-ND6 cells with MTG, as
fluorescence intensity emitted by MTG is directly proportional
to mitochondrial mass as assessed by flow cytometry. We also
opted to label the mitochondrial population with MTG, since
this dye accumulates in the lipid compartment in an MMP-
independent fashion (Pendergrass et al., 2004). Serum-
deprived control PC12 cells could not be stained with this
mitochondrial dye due to the compromised mitochondrial
membrane integrity upon serum deprivation, therefore remain-
ing non-fluorescent. Quantitative flow cytometry revealed that
the mitochondrial mass of PC12-ND6 cells remained constant
after 2 days of serum deprivation (Figure 1B).
To complement our quantification analysis, we measured
another indicator of mitochondrial mass, mitochondrial area
(Baxter et al., 2009), by labelling serum-grown and serum-
deprived PC12-ND6 cells with the plasma membrane marker,
Alexa FluorH 488-conjugated WGA, the mitochondrial dye
MTR, and the nuclear counterstain TO-PROH-3 followed by
confocal fluorescence analysis. Serum-deprived control PC12
cells could not be stained with MTR, as this dye cannot be
retained in the mitochondrial matrix when the mitochondrial
membrane is compromised (Deshmukh et al., 2000; Buckman
et al., 2001). Mitochondrial area was calculated using the
plasma membrane and nuclear stains to delineate the
cytoplasm and MTR to stain the mitochondrial population.
We found no statistically significant difference in the
mitochondrial area of serum-grown and serum-deprived
PC12-ND6 cells (Figure 1C). Taken together, these results
reveal that NeuroD6 maintains the mitochondrial mass of
PC12-ND6 cells upon removal of trophic factors, in keeping
with the previously reported NeuroD6 neuro-protective
properties using our PC12-ND6 cellular paradigm and
withdrawal of trophic factors (Uittenbogaard and
Chiaramello, 2005; Uittenbogaard et al., 2010).
Serum-deprived PC12-ND6 cells display
sustained intracellular ATP levels and expression
levels of specific subunits of respiratory
complexes, preventing mitochondrial
fractionation
The lack of variation in MTR labelling coupled with sustained
mitochondrial mass and COX4 expression levels in serum-
deprived PC12-ND6 cells (Figure 1C) is suggestive of main-
tained bioenergetic functions, as accumulation and retention
of MTR have been shown to be MMP (mitochondrial
membrane potential)-dependent (Pendergrass et al., 2004).
Thus we first assessed the intracellular ATP levels in control
PC12 and PC12-ND6 cells in the presence or absence of serum
for 24 and 48 h respectively. We opted for a flow cytometry
approach with the fluorescent dye Mg-Gr-AM, as previous
studies have established a correlation between MTR labelling
and ATP levels estimated by Mg-Gr-AM in Xenopus spinal
neurons (Lee and Peng, 2008). It has been well documented
that the fluorescence intensity of this probe decreases with
ATP content due to its higher binding affinity to ATP than
that to ADP (Leyssens et al., 1996; Bernstein and Bamburg,
2003). Quantitative flow cytometry revealed that serum
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119Figure 1 Constitutive expression of NeuroD6 results in sustained mitochondrial biomass upon serum deprivation
(A) Whereas PC12-ND6 cells retained their mitochondrial protein content after 48 h of serum deprivation, control PC12 cells lost
more than half of their mitochondrial protein content after 24 h of serum deprivation. Mitochondrial-enriched fractions were
isolated from serum-grown control PC12 and PC12-ND6 cells (t50) and serum-deprived control PC12 (t524 h) and PC12-ND6
(t548 h) cells. The protein content of mitochondrial fractions is expressed as a percentage of total protein content of the
corresponding whole cell extract (left-hand panel). Data are expressed as the means¡S.D. from three independent experiments
(*P50.0002 as compared with serum-grown control PC12 cells; **P50.0001 as compared with serum-deprived control PC12 cells;
***P50.0153 as compared with serum-grown PC12-ND6 cells; {P50.0001 as compared with serum-deprived control PC12 cells).
Expression levels of COX4 remained constant in mitochondrial-enriched fractions of PC12-ND6 cells after 48 h of serum deprivation
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levels (Figure 2A), consistent with the sustained fluorescence
intensity emitted by the mitochondrial dye MTR (Figure 1C).
As expected, serum-deprived control PC12 cells lost more
than 50% of intracellular ATP, resulting in increased
fluorescence emission from Mg-Gr-AM (Figure 2A). Such
decreased ATP levels correlate with the collapsed COX4
expression levels in mitochondria-enriched fractions isolated
from serum-deprived (24 h) control PC12 cells and an overall
decrease in mitochondrial content (Figure 1A). Moreover,
they are in full concordance with the well-documented
catastrophic PC12 cell death after 24 h of serum deprivation
(Stefanis et al., 1996, 1998; Troy et al., 1997; Franc ¸ois et al.,
2001; Vyas et al., 2004; Uittenbogaard and Chiaramello, 2005)
and the recently reported 40% loss of mitochondrial
membrane depolarization of PC12 cells after 24 h of serum
deprivation (Krzyzanski et al., 2007).
To understand how PC12-ND6 cells maintain their intracel-
lular ATP levels upon serum deprivation, we examined the
expression levels of the a-subunit of the ATP synthase
(complex V), as our genome-wide microarray analysis revealed
a 1.52-fold increaseinserum-deprivedPC12-ND6cellsafter48
h (Uittenbogaard et al., 2010). By immunoblot analysis, we
found that the a-subunit of the ATP synthase (complex V)
remained expressed at constant levels throughout serum
deprivation (Figure 2B). We complemented our immunoblot
analysis by examining the expression levels of the subunit
NDUFA9 of complex I and the core2 protein of complex III.
Although theirexpressionlevelsremainedunaltered duringthe
first 2 days of serum deprivation, they decreased 2- and 1.4-
fold respectively after 15 days of serum deprivation
(Figures 2C and 2D). Next, we assessed their localization by
immunocytochemistry, which confirmed their sustained
expression levels as well as their localization in growth cones
of serum-deprived PC12-ND6 cells (Figures 2B–2D).
Since a strong link exists between mitochondrial morphology
and bioenergetic functions, with an elongated morpho-
logy linked to the normal metabolic state and cell survival
and a fragmented morphology (spheroid-like) associated with
compromised respiratory activities and programmed cell death
(reviewed by Karbowski and Youle, 2003; Okamoto and Shaw,
2005; Chan 2006), we evaluated by confocal live cell imaging
whether PC12-ND6 cells maintained a healthy mitochondrial
population at distinct time points of serum deprivation. PC12-
ND6 cells were first transfected by electroporation using the
mito-GFP vector, which encodes the GFP with the mitochon-
drial targeting sequence from subunit VIII of human COX, and
were then serum-deprived after 24 h of transfection for
defined periods of time. Figure 3(A) shows that serum-grown
PC12-ND6 cells displayed a preponderance of elongated
mitochondria, as previously reported by immunocytochemistry
using fixed PC12-ND6 cells (Baxter et al., 2009). After 48 h of
serum deprivation, most mitochondria showed a short rod-like
morphology and a few showed an elongated morphology,
while spheroid-like fragmented mitochondria were rare
(Figure 3A). A similar overall mitochondrial morphology was
sustained after 6–9 days of serum deprivation (Figure 3A).
PC12-ND6 cells, which were serum-deprived for 15 days,
displayedelongatedmitochondria (Figure 3B),suggestiveofan
ongoing dynamic mitochondrial fusion–fission process, assoc-
iated with proper mitochondrial functions. Collectively, our
flow cytometry analysis and confocal live cell imaging have
revealed that NeuroD6 not only maintains the mitochondrial
biomass, but also a properly regulated mitochondrial fusion–
fission dynamics throughout the different phases of long-term
serum deprivation.
On the basis of the fact that PINK1 is critical for
mitochondrial integrity in several neuronal paradigms, with
PINK1 deficiency inducing mitochondrial fragmentation and
increased sensitivity to oxidative stress (Clark et al., 2006; Park
et al., 2006; Gautier et al., 2008; Wood-Kaczmar et al., 2008;
Dagda et al., 2009), we examined PINK1 expression levels upon
constitutive NeuroD6 expression and serum deprivation. We
consistently observed the expression level of the full-length
PINK1 protein to increase 1.7-fold in serum-grown PC12-ND6
cells, as compared with that of control PC12 cells by
immunoblot analysis (Figure 3B). We supplemented our
analysis by examining the expression levels of proteins known
to regulate mitochondrial morphology, such as the mitochon-
drial fusion Mfn2 (mitofusin 2) and OPA1 (optic atrophy 1)
proteins and the mitochondrial fission factor Drp1 (dynamin-
related protein 1) (reviewed by Lackner and Nunnari, 2009;
Thomas and Cookson, 2009). Among those proteins, only the
long OPA1 isoform showed a 2.6-fold increase in expression
(right-hand panel). Immunoblot analysis was performed using mitochondrial-enriched fractions isolated from serum-grown (0 h) and
serum-deprived (24 h) control PC12 as well as serum-grown (0 h) and serum-deprived (48 h) PC12-ND6 cells using a monoclonal
antibody against COX4. Equal loading was verified using an anti-GAPDH antibody. Molecular mass markers are indicated in kDa on
the left side of each Western blot panel. Results shown are representative of three independent experiments. Indicated quantification
values are specific to the blot shown, with an S.D. less than 10% compared with the corresponding replicates. (B) Quantification of
the fluorescence intensity of serum-grown and serum-deprived PC12-ND6 labelled with the mitochondrial dye MTG. PC12-ND6 cells
were first grown in a serum-containing medium before being serum-deprived for 48 h. PC12-ND6 cells were then stained with MTG
(70 nM) and analysed by flow cytometry. Flow cytometric profiles of serum-grown (t50) and serum-deprived (t548 h) PC12-ND6
labelled with MTG (left panel). Data are expressed as means¡S.D. from five independent experiments (right panel). There was no
statistical difference in the mitochondrial biomass of serum-deprived PC12-ND6 cells, as compared with serum-grown PC12 cells. (C)
The mitochondrial area of PC12-ND6 cells remains constant after 2 days of serum deprivation. To stain the mitochondrial
compartment, serum-grown (t50) and serum-deprived (t548 h) PC12-ND6 cells were labelled with MTR (red) and the plasma
membrane marker Alexa FluorH 488-conjugated WGA (green) and TO-PROH-3H (blue) (left panel; scale bar, 10 mm). The right panel
illustrates the quantification of mitochondrial area in serum-grown and serum-deprived PC12-ND6 cells. Data are expressed as the
means¡S.D. for three independent experiments with a minimum of n5150 cells for each culture condition. No statistically
significant variation of the mitochondrial area was observed on serum deprivation of PC12-ND6 cells.
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121Figure 2 Serum-deprived PC12-ND6 cells sustain intracellular ATP levels and expression levels of specific subunits of the respiratory
complexes I, III and V
(A) Intracellular ATP levels of PC12-ND6 cells remained constant after 2 days of serum deprivation, while serum-deprived control
PC12 cells (for 24 h) lost half of their original ATP levels. Serum-grown and serum-deprived control PC12 and PC12-ND6 cells were
labelled with Mg-Gr-AM (10 mM) for 30 min at 37˚C before being analysed with a FACSCalibur
TM flow cytometer. Data were
collected from 20000 cells and three independent experiments. Mg-Gr decreases emission intensity (lex5475 nm; lem5530 nm)
with an increase in ATP levels due to its high binding affinity to ATP, as compared with that of ADP. Results are expressed as relative
fluorescence intensity. No statistically significant difference in intracellular ATP levels was observed after 2 days of serum deprivation
(P50.7992). (B) The a-subunit of the ATP synthase (COXV) remains steadily expressed throughout the duration of serum deprivation
in PC12-ND6 cells. Immunoblot analysis was performed using whole-cell extracts from serum-grown PC12-ND6 cells and PC12-ND6
cells serum-deprived for the indicated periods of time. Equal loading was verified using an anti-GAPDH antibody. Molecular masses
in kDa are indicated on the left side of each Western blot panel. The left-hand panel shows immunoblot results representative of
three independent experiments. Indicated quantification values are specific to the blot shown, with an S.D. less than 10% compared
with the corresponding replicates. The right-hand panel illustrates the representative immunocytochemistry showing the retained
mitochondrial localization of the a-subunit of the ATP synthase (COX5) on serum deprivation (scale bar, 10 mm). (C) The subunit
NDUFA9 of complex I remains expressed throughout the duration of serum deprivation in PC12-ND6 cells, albeit at lower levels after
6 days of serum removal. The left-hand panel shows immunoblot results representative of at least three independent experiments.
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competent form of OPA1 in the rat species (Ishihara et al.,
2006). Finally, the PINK1 protein remained uncleaved and
expressed throughout the wholedurationofserumdeprivation
(Figure 3C), an observation that is in keeping with the overall
mitochondrial morphology observed in serum-deprived PC12-
ND6 cells. Thus our collective results support the notion that
constitutive expression of NeuroD6 not only allows serum-
deprived PC12-ND6 cells to retain a steady healthy mitochon-
drial population, but also to sustain intracellular ATP levels and
expression levels of key subunits of respiratory complexes I, III,
IV and V.
PGC-1a, Tfam (transcription factor A,
mitochondrial) and NRF-1 (nuclear respiratory
factor-1) expression levels are sustained in
serum-deprived PC12-ND6 cells
To initiate our studies on the NeuroD6-mediated transcrip-
tional pathways responsible for maintenance of the mito-
chondrial biomass throughout serum deprivation, we
examined the expression levels of key transcriptional
regulators, known to stimulate mitochondrial biogenesis,
such as the master transcriptional co-activator PGC-1a and
the nuclear-encoded transcriptional regulators, Tfam and
NRFs NRF-1 and -2 (reviewed by Kelly and Scarpulla, 2004;
Scarpulla 2008).
We initially focused on PGC-1a expression levels using a
polyclonal antibody raised against the N-terminal domain of
PGC-1a (Table 1), as PGC-1a not only regulates mitochon-
drial biogenesis, but also confers protection from oxidative
stress in the brain (St-Pierre et al., 2006; Wareski et al., 2009).
We detected two predominant isoforms of full-length PGC-1a
as well as the recently identified truncated form of PGC-1a (35
kDa), NT-PGC-1a (N-terminal-truncated PGC-1a; Figure 4A).
This truncated form has been shown to be transcriptionally
competent to activate a subset of known PGC-1a target genes
in brown adipocyte tissue (Zhang et al., 2009). Interestingly,
NT-PGC-1a remained expressed at constant levels throughout
the whole duration of serum deprivation, whereas the full-
length PGC-1a expression levels rapidly decreased 11-fold
after 4 h of serum removal, failing to display a recovery after
48 h of serum deprivation (Figure 4A). Thus the dynamics of
PGC-1a expression pattern suggests that the truncated form
of NT-PGC-1a rather than the full-length PGC-1a may be
involved in maintaining the mitochondrial mass upon serum
deprivation.
We supplemented our analysis by examining the expression
levels of Tfam in serum-deprived PC12-ND6 cells, since Tfam
regulates mitochondrial transcription and maintenance of
mtDNA copy number (Ekstrand et al., 2004; Kanki et al., 2004;
Ikeuchi et al., 2005; Cotney et al., 2007). We found that serum
deprivation of PC12-ND6 cells triggered only a negligible
decrease (1.3-fold) of the mitochondrial form of Tfam protein
(Figure 4B). These Tfam levels are in keeping with the
maintained mitochondrial mass in serum-deprived PC12-
ND6 cells assessed by flow cytometry, confocal microscopy
and mitochondrial-enriched fractionation (Figure 1).
Since recent studies have shown that the transcriptional co-
activator PGC-1a interacts with NRF-1 to stimulate mitochon-
drial biogenesis by activating the transcription of all ten
subunits of COX in neurons (Dhar et al., 2008), we investigated
whether NRF-1 expression levels paralleled PGC-1a and Tfam
levels in serum-deprived PC12-ND6 cells. By immunoblot
analysis, we showed a tight correlation between PGC-1a, Tfam
and NRF-1 expression levels throughout serum deprivation
(Figure 4C). Finally, we also examined the expression levels of
NRF-2 [GABP-a (GA-binding protein-a)] in serum-deprived
PC12-ND6 cells, as NRF-2 in conjunction with the transcrip-
tional co-regulator PGC-1a also regulates the expression of all
ten nuclear-encoded subunits of COX in neurons (Ongwijitwat
and Wong-Riley, 2005; Ongwijitwat et al., 2006) and Tfam
(Virbasius et al., 1993). We used a mouse monoclonal antibody
against the a-subunit of NRF-2 (GABP-a), as this subunit is
required for NRF-2 DNA-binding activity (Batchelor et al.,
1998). GABP-a expression levels were barely detectable, with a
12-fold decrease after 2 days of serum deprivation (Figure 4D),
suggesting that maintenance of the mitochondrial mass and
mtDNA copy number via Tfam expression upon serum
deprivation does not require NRF-2-mediated transcriptional
regulation. Collectively, our results support the notion that
NeuroD6 triggers a specific transcriptional programme to
maintain the mitochondrial biomass of serum-deprived PC12-
ND6 cells in order to mediate neuronal survival and
mitochondrial integrity as previously reported (Uittenbogaard
and Chiaramello, 2005; Uittenbogaard et al., 2009).
Constitutive expression of NeuroD6 prevents
generation of the ROS superoxide anions upon
serum deprivation
Based on our recent finding that serum-grown PC12-ND6
cells produce more ATP than the serum-grown control PC12 cells
(Baxter et al., 2009), combined with the fact that the main source
Indicated quantification values are specific to the blot shown, with an S.D. less than 10% compared with the corresponding
replicates. The right-hand panel illustrates representative immunocytochemistry showing the retained mitochondrial localization of
the subunit NDUFA9 upon serum deprivation. Cells were labelled with an anti-NDUFA9 monoclonal antibody and the nuclear
counterstain DAPI before being analysed by confocal fluorescence microscopy (scale bar, 10 mm). (D) The core2 protein of COX3
remains expressed throughout the duration of serum deprivation in PC12-ND6 cells. The left-hand panel shows immunoblot results
representative of three independent experiments. Indicated quantification values are specific to the blot shown, with an S.D. less
than 10% compared with the corresponding replicates. The right-hand panel illustrates the representative immunocytochemistry
showing the retained mitochondrial localization of the core2 protein of COX3 on serum deprivation (scale bar, 10 mm).
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123of electron leakage originates from the mitochondrial ETC to
reduce O2 to the predominant form of ROS superoxide anions
(Turrens, 1997; Demin et al., 1998), we investigated whether
such an increased energy production would result in higher
levels of superoxide anions (O2
2) than that in control PC12
cells. To address this question, we measured relative levels of
O2
2 using the redox-sensitive dye, MitoSOX
TM, which is a
fluorogenic dye for highly selective detection of superoxide
Figure 3 Analysis of mitochondrial morphology by live cell imaging and expression levels of proteins involved in mitochondrial fusion
and fission prior to and after serum removal
(A) Live cell confocal fluorescence imaging of serum-grown and serum-deprived PC12-ND6 cells. PC12-ND6 cells were first transfected
with the mito-GFP vector to label the mitochondrial mass and then switched to a serum-free medium for the indicated periods of time.
Mitochondrial morphology was assessed by confocal fluorescence microscopy using a 6100 oil objective and an environmental
chambertokeeptheCO2levelandtemperatureconstant.Theleftpanelsshow GFP-labelledmitochondria,whilethemiddlepanelsshow
the merge with the corresponding DIC pictures. The right panels show high magnification of the labelled mitochondria (large arrows for
elongatedmitochondriaandsmallforrod-likemitochondria).Scalebar,5mm.(B)Highmagnificationofserum-deprivedPC12-ND6cells
transfected with the mito-GFP vector. This image illustrates the range of mitochondrial length, suggestive of a dynamic fusion–fission
activity even after 15 days of serum deprivation. Scale bar, 5 mm. (C) Expression profile of protein involved in the fusion–fission process
of mitochondria. Immunoblot analyses were performed using whole-cell extracts from serum-grown control PC12 and PC12-ND6 cells
and equal loading was verified using an anti-GAPDH antibody. Relevant molecular masses (in kDa) are indicated on the left side of each
Western blot panel. The immunoblots are representative of at least three independent experiments. Indicated quantification values are
specific to the blot shown, with an S.D. less than 10% compared with the corresponding replicates. (D) Full-length PINK1 protein
remains expressed in serum-deprived PC12-ND6 cells, even after 15 days of serum deprivation. Immunoblot analysis was performed
using whole-cell extracts from PC12-ND6 cells grown in a serum-free medium for the indicated periods of time. Equal loading was
verified using an anti-GAPDH antibody. Relevant molecular masses (in kDa) are indicated on the left side of the Western blot panels.
Results shown are representative of three independent experiments. Indicated quantification values are specific to the blot shown, with
an S.D. less than 10% compared with the corresponding replicates.
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TM dye is live-cell-permeant and
selectively targeted to the mitochondria, we labelled live
control PC12 and PC12-ND6 cells with the MitoSOX
TM dye and
nuclear counterstain Hoechst 33342 and we measured by
confocal microscopy the amount of red fluorescence from
oxidized MitoSOX
TM dye, as an indicator of mitochondrial O2
2
levels (Johnson-Cadwell et al., 2007). Figure 5 shows that
serum-grown PC12-ND6 cells did not display higher levels of
O2
2 than serum-grown control PC12 cells.
Previous studies have demonstrated that serum deprivation
simulates oxidative stress in the context of the PC12 cellular
paradigm, resulting in ROS generation within 8 h of
treatment and ultimately inducing apoptosis within 24 h of
serum withdrawal (Rukenstein et al., 1991; Troy and
Shelanski, 1994; Satoh et al., 1996). Thus we investigated
whether constitutive expression of NeuroD6 would prevent
ROS generation on serum withdrawal. As expected, we
observed a 32-fold increase in superoxide anion levels in
control PC12 cells after 6 h of serum deprivation, which was
slightly more exacerbated after 24 h of serum deprivation to
reach a final 35-fold increase (Figures 5A and 5C). In
contrast, serum-deprived PC12-ND6 cells failed to display
increased levels of ROS within the first 24 h of serum
deprivation (Figures 5B and 5C). However, we observed a
slight increase by a factor of 5, after 48 h of serum
deprivation, levels that remained significantly lower than
those of serum-deprived PC12 cells (Figure 5). Collectively,
these results indicate that NeuroD6 protects PC12-ND6 cells
from generating significant levels of superoxide anions in
mitochondria, which is in keeping with our previous finding
of NeuroD6-mediated neuronal survival upon trophic factor
withdrawal via the mitochondrial pathway (Uittenbogaard
and Chiaramello, 2005; Uittenbogaard et al., 2009).
NeuroD6 sustains the expression of ROS
detoxifying enzymes during oxidative stress
mediated by serum deprivation
Because our recent genome-wide microarray analysis supple-
mented with a GSEA (gene set enrichment analysis) has
revealed a correlated expression between NeuroD6 and genes
Figure 4 Expression pattern of key regulators involved in mitochondrial biogenesis upon serum deprivation
The immunoblots are representative of three independent experiments. Equal loading was verified using an anti-GAPDH antibody and
the relevant molecular masses (in kDa) are indicated on the left side of each Western blot panel. Indicated quantification values are
specific to the blot shown, with an S.D. less than 10% compared with the corresponding replicates. (A) Only the expression levels of
the truncated form of PGC-1a, NT-PGC-1a, remain unaltered throughout serum deprivation of PC12-ND6 cells. The asterisks indicate
isoforms of the full-length PGC-1a. Quantification pertains to the full length of PGC-1a.( B) Tfam expression levels in PC12-ND6
cells were unaffected by serum deprivation. The mitochondrial-specific form of Tfam was the main form detected in both serum-
grown and serum-deprived PC12-ND6 cells. (C) Levels of NRF-1 expression remained steady throughout serum deprivation of PC12-
ND6 cells. (D) Levels of NRF2 expression collapsed 2 days after serum deprivation of PC12-ND6 cells.
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125involved in oxidative stress, ROS metabolism and the
molecular chaperone response prior to and during serum
deprivation (Uittenbogaard et al., 2010), we examined the
expression profile of the ROS detoxifying enzymes copper/
zinc SOD (SOD1), manganese SOD (SOD2), GPx1 (glutathione
peroxidase 1) and PRDX5 (peroxiredoxin 5) throughout 15
days of serum deprivation by immunoblot analysis to acquire
a perspective on the dynamic aspect of NeuroD6-mediated
tolerance to prolonged stress upon removal of trophic
factors.
We initially focused on the ROS detoxifying enzymes, SOD1
and SOD2, as they are critical for survival of PC12 cells upon
serum deprivation (Troy and Shelanski, 1994; Troy et al., 1996)
and, more importantly, as SOD2 protein is localized in the
mitochondrial matrix. We found that constitutive expression
of NeuroD6 not only increased the expression levels of both
Figure 5 Constitutive expression of NeuroD6 prevents ROS production upon serum deprivation
(A, B) Live cell confocal images of control PC12 and PC12-ND6 cells grown in the presence or absence of serum for 24 h before being
labelled with the MitoSOX
TM dye (red) and the nuclear counterstain Hoechst 33342 (blue). Images are representative of three
independent experiments. The left panels illustrate MitoSOX
TM-labelled cells before (t50) and after serum deprivation (t524 h),
while the right panels show the merge with the corresponding DIC pictures (scale bar, 10 mm). (C) Quantification of ROS production
at different time points of serum deprivation for control PC12 and PC12-ND6 cells. The mean fluorescence intensity of MitoSOX
TM
labelling was measured in the presence or absence of serum for 6 and 24 h in control PC12 and PC12-ND6 cells and for 48 h in PC12-
ND6 cells. At the outset of serum deprivation, we did not observe any statistical difference of ROS production between control PC12
and PC12-ND6 cells (P50.6074). The graph represents the averages from 150 cells from three independent experiments. {P50.0077
as compared with serum-grown control PC12 cells; *P50.0098 as compared with serum-deprived control PC12 cells for 6 h;
**P50.0004 as compared with serum-deprived control PC12 cells for 24 h; ***P50.0207 as compared with untreated PC12-ND6 cells.
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maintained their expression levels throughout the whole
period of serum deprivation (Figure 6A). We confirmed by
immunocytochemistry that SOD2 protein remained present in
the mitochondria of serum-deprived PC12-ND6 cells (results
not shown). In contrast, serum-deprived control PC12 cells
showed decreased expression levels of SOD1 and SOD2 (see
Supplementary Figure S1 at http://www.asnneuro.org/an/
002/an002e034add.htm).
Given the fact that our microarray analysis reflected a
1.81-fold increase in expression levels of PRDX5 mRNA
upon constitutive expression of NeuroD6 combined with its
known antioxidant and anti-apoptotic properties (Zhou et
al., 2000; Banmeyer et al., 2004, 2005; Dubuisson et al.,
2004; Wong et al., 2004; Kropotov et al., 2006; De Simoni
et al., 2008; Radyuk et al., 2009), we determined whether
such a direct correlation remained at the protein level
prior to and upon serum deprivation. By immunoblot
Figure 6 NeuroD6 triggers an antioxidant response in the absence of stress, which remains expressed throughout serum deprivation
The immunoblots are representative of three independent experiments. Equal loading was verified using an anti-GAPDH antibody.
Indicated quantification values are specific to the blot shown, with an S.D. less than 10% compared with the corresponding
replicates. (A) Constitutive expression of NeuroD6 results in increased expression of SOD1 and SOD2 in the absence of stress
stimulus, which remains unaltered during oxidative stress mediated by serum deprivation. (B) Expression levels of the antioxidant
regulators, Gpx1 and Prdx5, are increased upon constitutive expression of NeuroD6 and throughout the duration of serum
deprivation treatment. (C) SIRT1 expression increases in the absence of stress stimulus in serum-grown PC12-ND6 cells, while
remaining constant for up to 6 days of serum deprivation. Relevant molecular masses in kDa are indicated on the left side of each
Western blot panel.
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127analysis, we validated that the protein PRDX5 was indeed
significantly up-regulated 2.3-fold upon constitutive
expression of NeuroD6 (Figure 6B). Most importantly,
PRDX5 expression levels steadily increased throughout the
whole serum deprivation treatment, to a final 2.6-fold
after 15 days of serum deprivation, suggesting a potential
pivotal role in the long-term NeuroD6-mediated tolerance
to oxidative stress (Figure 6B). In contrast, control PC12
cells, which expressed very low levels of PRDX5 even in the
presence of serum, maintained negligible levels of PRDX5
expression after 24 h of serum deprivation (see Supplemen-
tary Figure S1).
We next examined the expression levels of another ROS
detoxifying enzyme, GPx1, as our genome-wide microarray
analysis revealed a 1.54-fold increase at the mRNA level
(Uittenbogaard et al., 2010) and it plays a well-established
role in the O2 reduction pathway associated with mitochon-
drial respiratory functions (reviewed by D’Autre ´aux and
Toledano, 2007; Giorgio et al., 2007). We found that
NeuroD6 by itself was sufficient to stimulate levels of the
GPx1 protein 1.5-fold, which further increased by up to 1.6-
fold throughout oxidative stress mediated by serum depriva-
tion (Figure 6B). Again, serum-deprived control PC12 cells
failed to maintain GPx1 expression levels (see Supplementary
Figure S1). We supplemented our immunoblot analysis by
examining the expression levels of another detoxifying
enzyme, catalase, which revealed substantially decreased
levels of catalase in serum-deprived PC12-ND6 cells (results
not shown), implying its lack of involvement in NeuroD6-
mediated tolerance to oxidative stress and control of ROS
production.
Given that PC12 cells transiently express the mammalian
NAD-dependent deacetylase orthologue of the yeast silent
information regulator 2, SIRT1, after 16 h of serum
deprivation (Nemoto et al, 2004; Wu et al., 2006), combined
with its role in cellular energy and redox homoeostasis
(Fulco et al., 2003; Brunet et al., 2004; Nemoto et al.,
2005), embryonic brain development (Cheng et al., 2003;
McBurney et al., 2003; Sakamoto et al., 2004; Prozorovski
et al., 2008) and neuroprotection in the context of
neurodegenerative diseases (Parker et al., 2005; Sinclair
2005), we investigated whether NeuroD6 could up-regulate
SIRT1 expression independently of a stress stimulus or only
upon serum deprivation. In the presence of serum, the
SIRT1 protein was expressed in PC12-ND6 cells, while it was
absent in control PC12 cells (Figure 6C), in keeping with the
reported studies (Nemoto et al., 2004). Interestingly, serum
deprivation did not result in a further increase in SIRT1
expression levels in PC12-ND6 cells, but rather resulted in
sustained expression levels for up to 6 days of treatment
before collapsing after 15 days of serum removal
(Figure 6C). Collectively, these results indicate that
NeuroD6 triggers a comprehensive antioxidant response in
the absence of stress, which generates a reserve of
antioxidant ready to inactivate generated ROS upon serum
deprivation thereby maintaining ROS homoeostasis.
DISCUSSION
Given the ability of NeuroD6 to increase the mitochondrial
biomass in the early stages of neuronal differentiation (Baxter
et al., 2009) and to trigger a comprehensive anti-apoptotic
response and a molecular chaperone network through the
expression of multiple HSPs (Uittenbogaard and Chiaramello,
2005;Uittenbogaard et al.,2009, 2010),we extendedourstudy
onthe neuroprotective properties of NeuroD6 by investigating
whether constitutive expression of NeuroD6 could concomi-
tantly regulate the mitochondrial biomass and ROS hom-
oeostasis upon oxidative stress mediated by serum
deprivation, as suggested by our recent genome-wide
microarray analysis (Uittenbogaard et al., 2010). In the
present study, we report a novel role for NeuroD6 as a
regulator of ROS homoeostasis, resulting in enhanced
tolerance to oxidative stress. First, constitutive expression
of NeuroD6 results in sustained mitochondrial mass upon
oxidative stress triggered by withdrawal of trophic factors as
shown by distinct but complementary experimental
approaches, such as flow cytometry, confocal fluorescence
microscopy and mitochondrial fractionation. Secondly,
NeuroD6-mediated maintenance of mitochondrial mass is
accompanied by sustained intracellular ATP levels and
expression of specific subunits of distinct respiratory
complexes located in the mitochondrial inner membrane.
Thirdly, serum-deprived PC12-ND6 cells bear mitochondria
displaying an elongated morphology compatible with bio-
energetic capacity to ensure cell survival upon withdrawal of
trophic factors. Fourthly, NeuroD6 sustains the expression of
the transcriptional co-activator PGC-1a and the nuclear-
encoded transcription factors Tfam and NRF-1, all of them
known to regulate mitochondrial biogenesis. Lastly, NeuroD6
triggers a comprehensive antioxidant response in the
absence of stress, which endows PC12-ND6 cells with
intracellular ROS scavenging capacity, resulting in low ROS
levels upon oxidative stress.
In view of the prevailing theory that oxidative stress,
mitochondrial dysfunction and impaired protein folding/
degradation are common underlying causes for many
neurodevelopmental disorders, neurodegenerative diseases
and brain aging (reviewed by Wallace, 2005; Lin and Beal,
2006; Giorgio et al., 2007; Nicholls, 2008), the ability of
NeuroD6 to regulate these three interconnected pathways
may provide therapeutic opportunities to mediate neuropro-
tection. This is particularly relevant in the context of NeuroD6
exclusive expression in the entorhinal cortex and subiculum
(Schwab et al., 1998), two areas of the brain to undergo
degeneration at the very early stages of AD (Braak and Braak,
1991; deToledo-Morrell et al., 2004) and to functionally
connect the hippocampus to the neocortex (de la Prida et al.,
2006; Yasuda and Mayford, 2006), where NeuroD6 is also
highly expressed. To our knowledge, our collective studies
provide the first demonstration of a neurogenic bHLH
transcription factor able to concomitantly co-ordinate the
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survival, molecular chaperone network, mitochondrial bio-
genesis and ROS homoeostasis (Figure 7), pathways known to
be dysregulated in many neurodegenerative diseases, result-
ing in compromised mitochondrial integrity and aberrant
mitochondrial homoeostasis (reviewed by Nicholls and Budd,
2000; Greene et al., 2004; Langley and Ratan, 2004; Herrup
and Yang, 2007; Wyttenbach and Arrigo, 2007; Mattson et al.,
2008; Nicholls, 2008; Gibson et al., 2010).
Given the central importance of the transcriptional co-
activator PGC-1a to control mitochondrial biogenesis and
bioenergetic functions in various cellular differentiation
paradigms, such as brown adipocyte and muscle cell
differentiation (reviewed by Scarpulla, 2008; Hock and
Kralli, 2009), and more recently in neuronal paradigms
(Cowell et al., 2007; Meng et al., 2007; Wareski et al.,
2009), we examined the expression of the transcriptional co-
activator PGC-1a in serum-deprived PC12-ND6 cells
throughout the entire period of serum deprivation. To our
surprise, expression levels of the full-length PGC-1a protein
rapidly collapsed after 4 h of serum deprivation, while the NT-
PGC-1a isoforms remained expressed at constant levels
throughout the whole serum deprivation treatment.
NT-PGC-1a, a recently discovered isoform of PGC-1a,
contains an in-frame stop codon as a result of alternative
39 splicing, which gives rise to a truncated PGC-1a form
carrying only the transactivation and nuclear receptor
interaction domains (Zhang et al., 2009). More importantly,
NT-PGC-1a is not only expressed at the highest level in rat
brain, when compared with that of liver and brown adipose
tissue, but also its spliced form is also favoured over the full-
lengthform(Zhangetal.,2009).Thenotion thatthefull-length
and truncated forms of PGC-1a have unique functions has
been articulated based on the retention of a subset of shared
functional domains (Zhang et al., 2009), which is further
strengthened by their non-overlapping expression profiles in
PC12-ND6 cells throughout serum deprivation. Future studies
addressing NT-PGC-1a’s regulatory role in modulating
mitochondrial mass within the context of neuronal differ-
entiation and survival using our cellular paradigm are
relevant based on the recent evidence of NT-PGC-1a
enhancing mitochondrial biogenesis in brown adipocytes
(Zhang et al., 2009).
In view of the integrative role of PGC-1a in co-ordinating
a network of nuclear-encoded transcription factors respons-
ible for mitochondrial gene expression, we examined the
expression levels of the transcription factors NRF-1 and NRF-
2 (GABP-a), whose transcriptional activities are known to be
Figure 7 Working model of NeuroD6-mediated tolerance to oxidative stress
This comprehensive working model integrates newly identified transcriptional modules with modules identified in our published
studies (Uittenbogaard and Chiaramello, 2004, 2005; Baxter et al., 2009; Uittenbogaard et al., 2010), as indicated with asterisks.
Whereas representative markers for each module are indicated in blue-framed boxes, the corresponding cellular processes are
specified in blue elliptical objects.
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129regulated upon protein–protein interactions with PGC-1a
(reviewed by Scarpulla, 2008; Hock and Kralli, 2009).
Interestingly, NRF-1 and NRF-2 (GABP-a) did not display a
similar expression profile upon serum deprivation. While a
tight correlation between expression levels of NT-PGC-1a and
NRF-1 was detected during the whole duration of serum
deprivation, it did not apply to the DNA-binding subunit
GABP-a. Such expression profiles suggest that GABP-a is not
necessary to maintain the mitochondrial biomass as well as
the expression of genes encoding mitochondrial proteins
upon stress in neuronal PC12-ND6 cells. This notion is further
reinforced by a previous study using conditional gabp-a
mutant mice demonstrating that GABP-a is not essential for
mitochondrial biogenesis and corresponding gene expression
in skeletal muscle cells (Jaworski et al., 2007). The fact that a
direct correlation has been observed between expression of
GABP-a and several respiratory enzymes upon neural activity
but in the absence of a stress stimulus (Zhang and Wong-
Riley, 2000; Yang et al., 2004; Wong-Riley et al., 2005)
highlights the influence of the cellular context in favouring
NRF-1- over NRF-2-mediated transcriptional pathways. This
may be further explained by the notion that each transcription
factor has broad developmental functions beyond mitochon-
drial biogenesis and respiratory functions, as NRF-1- and NRF-
2-null mice display pre-implantation lethality (Huo and
Scarpulla, 2001; Ristevski et al., 2004). Thus it appears that
NRF-1 and NRF-2 have the ability to distinctly co-ordinate
mitochondrial functions by tailoring nucleo-mitochondrial
interactions to a specific cellular context, such as differenti-
ation, stress stimulus and cell lineage.
Given the functional interplay between mitochondrial
morphology and functions (reviewed by Karbowski and Youle,
2003; Chen and Chan, 2009; Lackner and Nunnari, 2009), we
confirmed the absence of mitochondrial fragmentation
throughoutserumdeprivationbylivecellconfocalfluorescence
microscopy. This is in keeping with sustained levels of the
serine/threonine kinase PINK1 protein in PC12-ND6 cells
throughout the whole duration of serum deprivation. PINK1,
which is located in both the cytosol and mitochondria via an N-
terminalmitochondrialtargetingsequence(Valenteetal.,2004;
Zhou et al., 2008), regulates mitochondrial morphology in
several neuronal paradigms (reviewed by Thomas and Cookson,
2009). In addition, our observations of sustained expression of
mitochondrial OXPHOS (oxidative phosphorylation) complex
subunits, intracellular ATP levels, fluorescence intensity emitted
by the MTR dye, whose accumulation and retention are MMP
dependent, are congruent with the notion that NeuroD6
confers tolerance to oxidative stress by sustaining the content
of energized mitochondria.
Finally, the present study has revealed a novel role for
NeuroD6 in mediating a comprehensive antioxidant response
in the absence of stress, thereby generating an antioxidant
reserve to enhance tolerance to oxidative stress. The NeuroD6
effect is not limited to the classic induction of the ROS-
scavenging enzymes, such as SOD1, SOD2, GPx1 and PRDX5,
but also to recently identified powerful suppressors of ROS,
such as PGC-1a, PINK1 and SIRT1. PINK1 possesses neuro-
protective properties via its catalytic properties (Haque et al.,
2008) and confers tolerance to oxidative stress by preventing
mitochondrial fragmentation and subsequent increased ROS
production in neuronal cells (Benard and Rossignol, 2008;
Wood-Kaczmar et al., 2008; Dagda et al., 2009; Thomas and
Cookson, 2009). Also key is the role of PGC-1a as a broad and
robust regulator of ROS metabolism in addition to its well-
established role as a regulator of mitochondrial biogenesis
(St-Pierre et al., 2006; Wareski et al., 2009), which is
consistent with the reported neurodegenerative lesions in
the brains of PGC-1a-null mice (Lin et al., 2004; Leone et al.,
2005). The co-expression of PGC-1a and two major ROS-
detoxifying mitochondrial enzymes, SOD2 and GPx1, in PC12-
ND6 cells prior to and during oxidative stress bears
mentioning in the context that PGC-1a has been reported
to induce their expression in neuronal cells (St-Pierre et al.,
2003, 2006; Valle et al., 2005; Kukidome et al., 2006).
Similarly important is the co-ordinate expression of SOD2 and
the NAD-dependent class III protein deacetylase, SIRT1, in
PC12-ND6 cells prior to and during serum deprivation, in
keeping with its well-documented transcriptional control of
the SOD2 gene (Nemoto and Finkel, 2002; Brunet et al., 2004;
Daitoku et al., 2004). Moreover, expression of the endogenous
SIRT1 protein in serum-grown PC12-ND6 cells may be a result
of the constitutive expression of NeuroD6, as SIRT1 protein is
known to be transiently expressed upon short-term serum
starvation in the parental PC12 cell line (Nemoto et al., 2004).
Of interest is the co-expression of PGC-1a and SIRT1 in
serum-grown PC12-ND6 cells in light of the fact that SIRT1
deacetylates PGC-1a to stimulate its transcriptional activity
(Nemoto et al., 2005; Wareski et al., 2009). Such a PGC-1a–
SIRT1 functional interaction may contribute to the NeuroD6-
mediated increase in mitochondrial mass in the absence of
stress. Further studies need to be carried out to investigate
such interactions and their functional impact in regulating
mitochondria density within the context of NeuroD6-
mediated transcriptional pathways and oxidative stress.
In summary, our collective results support the concept that
the NeuroD6–PGC–1a–SIRT1 neuroprotective axis may be
critical in achieving a balance between the mitochondrial
biomass and antioxidant reserve to confer tolerance to
oxidative stress. Thus NeuroD6 may constitute an instructive
target towards the design of novel therapeutic strategies for
the treatment of neurodegenerative diseases characterized by
a mitochondrial deficit and oxidative damage.
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